The Latest
Long-Acting Injectable HIV Combo Administered Every Two Months Effective in Phase 3 Trial
Multidrug-Resistant Salmonella Outbreak Characterized
Coverage With HPV Vaccine Continuing to Increase in Boys
Class I Recall Issued for Transcatheter Heart Valve Delivery System
Treatment Granted Orphan Drug Status for Acute Radiation Syndrome
Supplemental NDA for Xtandi Accepted and Granted Priority Review
Strategies to Reduce Rx Costs Examined Among Patients With Diabetes
CERC-802 Receives Fast Track Status for Rare Metabolic Disorder
NDA Submitted for First-in-Class Acne Cream
MPR ARTICLES
